American Beacon ARK Transformational Innovation Fund CRSP Holdings History
American Beacon ARK Transformational Innovation Fund's CRISPR Therapeutics AG Holding Summary
As of 2025-03-31, AMERICAN BEACON FUNDS held 216,500.00 shares of CRISPR Therapeutics AG(CRSP), totaling $7.37 Mil. This investment constitutes 4.95% of their stock portfolio, and AMERICAN BEACON FUNDS now holds 0.25% of the outstanding CRISPR Therapeutics AG(CRSP) stock.
The initial trade took place in 2019Q3. And since then American Beacon ARK Transformational Innovation Fund has made 8 purchases of CRSP, at an average price of $55.74, for a total of 358,572.00 shares. In addition, there have been 9 sales at an average price of $73.52 for 142,072.00 shares. Based on historical transaction data and CRSP's current price of $60.08, American Beacon ARK Transformational Innovation Fund's estimated gain on his CRSP holdings is $3.47 Mil, reflecting a 17.35% gain to date.
American Beacon ARK Transformational Innovation Fund CRSP ($60.08) Holding Chart
American Beacon ARK Transformational Innovation Fund CRSP ($60.08) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1